HUTCHMED (China) Ltd
LSE:HCM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HUTCHMED (China) Ltd
LSE:HCM
|
HK |
|
Obsidian Energy Ltd
TSX:OBE
|
CA |
|
Costar Group Inc
NASDAQ:CSGP
|
US |
Intrinsic Value
The intrinsic value of HUTCHMED (China) Ltd (HCM) under the Base Case is 176.96 GBX per share. Compared with the current market price of 208 GBX, the stock appears Overvalued by 15% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What HUTCHMED (China) Does
HUTCHMED is a biopharmaceutical company that discovers and develops cancer medicines, especially targeted therapies and immunotherapies. It also works on treatments for immune and inflammatory diseases. The company’s main job is to take drug candidates from research into clinical testing and then turn the successful ones into approved medicines for patients.
- Headquarters
- Hong Kong HK
- Employees
- 1 796
- IPO date
- May 19, 2006
Earnings Waterfall
HUTCHMED (China) Ltd
The intrinsic value for HUTCHMED (China) Ltd (HCM) under the Base Case is 176.96 GBX.
Compared with the current market price of 208 GBX, the stock appears Overvalued by 15% .